F Dx Advisors, Inc. Abb Vie Inc. Transaction History
F Dx Advisors, Inc.
- $308 Million
- Q1 2025
A detailed history of F Dx Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, F Dx Advisors, Inc. holds 2,723 shares of ABBV stock, worth $513,339. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,723
Previous 2,722
0.04%
Holding current value
$513,339
Previous $484,000
17.98%
% of portfolio
0.19%
Previous 0.14%
Shares
34 transactions
Others Institutions Holding ABBV
# of Institutions
4,251Shares Held
1.27BCall Options Held
16.6MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA174MShares$32.8 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.1 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.3 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.76 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $333B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...